![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Leichsenring, Jonas; Vladimirova, Valentina; Solbach, Christine; Karn, Thomas; Ataseven, Beyhan; Sinn, Bruno Valentin; Barinoff, Jana; Mueller, Volkmar; Blohmer, Jens-Uwe; Schem, Christian; Engels, Knut; Marme, Frederik; Fisseler-Eckhoff, Annette; Fasching, Peter A.; Stickeler, Elmar; Mackelenbergh, Marion van; Denkert, Carsten; Stenzinger, Albrecht; Loibl, Sibylle und Groeschel, Stefan
(2022):
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
In: BMC Cancer, Bd. 22, Nr. 1, 1040
Heitz, Florian; Kümmel, Sherko; Lederer, Bianca; Solbach, Christine; Engels, Knut; Ataseven, Beyhan; Sinn, Bruno; Blohmer, Jens Uwe; Denkert, Carsten; Barinoff, Jana; Fisseler-Eckhoff, Annette und Loibl, Sibylle
(2019):
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
In: Geburtshilfe und Frauenheilkunde, Bd. 79, Nr. 10: S. 1110-1117
Denkert, Carsten; Budczies, Jan; Regan, Meredith M.; Loibl, Sibylle; Dell'Orto, Patrizia; Minckwitz, Gunter von; Mastropasqua, Mauro G.; Solbach, Christine; Thurlimann, Beat; Mehta, Keyur; Blohmer, Jens-Uwe; Colleoni, Marco; Müller, Volkmar; Klauschen, Frederick; Ataseven, Beyhan; Engels, Knut; Kammler, Roswitha; Pfitzner, Berit M.; Dietel, Manfred; Fasching, Peter A. und Viale, Giuseppe
(2019):
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII+IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
In: Breast Cancer Research and Treatment, Bd. 176, Nr. 3: S. 557-568
Rody, Achim; Holtrich, Uwe; Pusztai, Laos; Liedtke, Cornelia; Gaetje, Regine; Ruckhaeberle, Eugen; Solbach, Christine; Hanker, Lars; Ahr, Andre; Metzler, Dirk; Engels, Knut; Karn, Thomas und Kaufmann, Manfred
(2009):
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
In: Breast Cancer Research
11:R15
[PDF, 2MB]